It is certainly reasonable to expect that removing 2 million HER2 proteins from the plasma membrane of a breast cancer cell is far more likely to be a fatal and disruptive membrane insult than if only 20,000 CD20 proteins are excised from a CLL cell. Here, ERBB2 is linked to B-cell chronic lymphocytic leukemia.